{"schema_version":"alpha-profile-public-v1","slug":"mark-enyedy","canonical_url":"https://registry.alpha.ac/people/mark-enyedy","as_of":"2026-09-21T16:56:42.362266+00:00","published_at":"2026-09-02T02:37:23.760549+00:00","last_reviewed_at":"2026-05-16T03:50:21.697+00:00","identity":{"display_name":"Mark Enyedy","headshot_url":"https://qzvwmfoixeflcbvpqboy.supabase.co/storage/v1/object/public/director-photos/directors/032e2d04-f9bd-4a6c-9eb7-96bcfed740ee.jpg","headshot_media":{"asset_id":"alpha-profile-portrait:mark-enyedy:v1","canonical_url":"https://qzvwmfoixeflcbvpqboy.supabase.co/storage/v1/object/public/director-photos/directors/032e2d04-f9bd-4a6c-9eb7-96bcfed740ee.jpg","alt_text":"Portrait of Mark Enyedy","caption":"Mark Enyedy profile portrait","source_name":"Alpha governed canonical profile record","source_url":"https://qzvwmfoixeflcbvpqboy.supabase.co/storage/v1/object/public/director-photos/directors/032e2d04-f9bd-4a6c-9eb7-96bcfed740ee.jpg","rights":null,"authenticity_class":null,"published_at":"2026-09-02T02:37:23.760549+00:00","current_version":1},"profile_kind":"director","role_tags":["director","board"],"current_role":{"company_name":"Charles River Laboratories","company_slug":"charles-river-laboratories-international-inc","exchange":"NYSE","ticker":"CRL","role_category":"director","title":"Independent Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2025-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1100682/000110465926037367/tm261421-1_def14a.htm","effective_date":"2026-03-31","last_checked_at":"2026-05-03T01:22:00.921+00:00"}},"photo_match":"person_record"},"assurance":{"is_claimed":false,"status":"unverified","assurance_level":null,"method":null,"verified_at":null,"expires_at":null},"claiming":{"eligible":true,"label":"Is this you? Claim your Alpha Profile","claim_url":"https://terminal.alpha.ac/claim-profile?person=mark-enyedy","suggest_edit_label":"Suggest an edit","suggest_edit_url":"https://terminal.alpha.ac/claim-profile?person=mark-enyedy&mode=suggest","canonical_record_will_be_reused":true,"canonical_facts_owner_controlled":false},"presentation":{"schema_version":"alpha-profile-presentation-v1","state":"alpha_editorial","version":0,"published_at":null,"headline":null,"headline_evidence":null,"location":null,"photo":null,"cover":null,"about":["Mr. Enyedy is former President and CEO of ImmunoGen (acquired by AbbVie in 2024). He has more than three decades of combined general management, business development, and legal experience in biotechnology. He previously served as CEO of Proteostasis Therapeutics and held diverse roles at Genzyme and Shire."],"links":[],"sources":[],"featured":[],"competencies":[],"board_preferences":null,"board_service":[{"organization":"Charles River Laboratories","organizationId":"charles-river-laboratories-international-inc","title":"Independent Director","period":"2025-01-01 · current","evidenceLabel":"sec_proxy","evidenceState":"verified","sourceUrl":"https://www.sec.gov/Archives/edgar/data/1100682/000110465926037367/tm261421-1_def14a.htm"},{"organization":"BIOMARIN PHARMACEUTICAL INC","organizationId":"biomarin-pharmaceutical-inc","title":"Director","period":"2023-01-01 · current","evidenceLabel":"sec_proxy","evidenceState":"verified","sourceUrl":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm"}],"experience":[],"education":[],"credentials":[],"section_order":null,"hidden_sections":[],"limitations":["Presentation fields do not alter independently verified Alpha Profile facts.","Owner-supplied résumé records retain their field-level evidence state.","Only confirmed company_person_roles with public evidence. Website governed_site_fallback rows are not invented. about/links are stored people.profile_summary/bio and linkedin_url only. Dates stay undisclosed when the role has no start_date. SoFi Bank is not SoFi Technologies."]},"presentation_authority":"confirmed_company_person_roles","roles":[{"company_name":"Charles River Laboratories","company_slug":"charles-river-laboratories-international-inc","exchange":"NYSE","ticker":"CRL","role_category":"director","title":"Independent Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2025-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1100682/000110465926037367/tm261421-1_def14a.htm","effective_date":"2026-03-31","last_checked_at":"2026-05-03T01:22:00.921+00:00"}},{"company_name":"BIOMARIN PHARMACEUTICAL INC","company_slug":"biomarin-pharmaceutical-inc","exchange":"NASDAQ","ticker":"BMRN","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2023-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm","effective_date":"2026-04-21","last_checked_at":"2026-05-07T00:23:06.905+00:00"}}],"claims":[{"claim_type":"ai_ml_experience","claim_value":false,"claim_text":"Proxy extraction classified AI/ML experience for Mark Enyedy as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T03:50:21.854482+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"CRL DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1100682/000110465926037367/tm261421-1_def14a.htm","published_at":"2026-03-31T00:00:00+00:00","last_checked_at":"2026-05-16T03:50:21.75247+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"board_role","claim_value":"Director","claim_text":"Mark J. Enyedy currently serves as Director at BioMarin Pharmaceutical.","claim_state":"verified","valid_from":"2026-04-21","valid_to":null,"confidence":0.92,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-07T00:25:17.049478+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"BMRN DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm","published_at":"2026-04-21T00:00:00+00:00","last_checked_at":"2026-05-07T00:25:16.94839+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"board_role","claim_value":"Director","claim_text":"Mark Enyedy currently serves as Director at Charles River Laboratories International, Inc..","claim_state":"verified","valid_from":"2026-03-31","valid_to":null,"confidence":0.92,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T03:50:21.818449+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"CRL DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1100682/000110465926037367/tm261421-1_def14a.htm","published_at":"2026-03-31T00:00:00+00:00","last_checked_at":"2026-05-16T03:50:21.75247+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"committee_assignments","claim_value":["Nominating/Governance","Transactions and Strategy"],"claim_text":"Mark J. Enyedy serves on Nominating/Governance, Transactions and Strategy.","claim_state":"verified","valid_from":"2026-04-21","valid_to":null,"confidence":0.88,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-07T00:25:17.071139+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"BMRN DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm","published_at":"2026-04-21T00:00:00+00:00","last_checked_at":"2026-05-07T00:25:16.94839+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"committee_assignments","claim_value":["Corporate Governance and Nominating","Strategic Planning and Capital Allocation"],"claim_text":"Mark Enyedy serves on Corporate Governance and Nominating, Strategic Planning and Capital Allocation.","claim_state":"verified","valid_from":"2026-03-31","valid_to":null,"confidence":0.88,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T03:50:21.83639+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"CRL DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1100682/000110465926037367/tm261421-1_def14a.htm","published_at":"2026-03-31T00:00:00+00:00","last_checked_at":"2026-05-16T03:50:21.75247+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"cybersecurity_experience","claim_value":false,"claim_text":"Proxy extraction classified cybersecurity experience for Mark Enyedy as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T03:50:21.889433+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"CRL DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1100682/000110465926037367/tm261421-1_def14a.htm","published_at":"2026-03-31T00:00:00+00:00","last_checked_at":"2026-05-16T03:50:21.75247+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"technology_background","claim_value":false,"claim_text":"Proxy extraction classified technology background for Mark Enyedy as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T03:50:21.872544+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"CRL DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1100682/000110465926037367/tm261421-1_def14a.htm","published_at":"2026-03-31T00:00:00+00:00","last_checked_at":"2026-05-16T03:50:21.75247+00:00","relation":"supports","excerpt_locator":null}]},{"subject":"alpha:person:mark-enyedy","claim_type":"board_service","claim_value":{"tags":[],"title":"Independent Director","period":"2025-01-01 · current","organization":"Charles River Laboratories","organization_id":"charles-river-laboratories-international-inc"},"claim_text":"Independent Director at Charles River Laboratories (2025-01-01 · current)","valid_from":null,"valid_to":null,"verification_status":"confirmed","date_precision":"period_text_only","evidence":[{"source_url":"https://www.sec.gov/Archives/edgar/data/1100682/000110465926037367/tm261421-1_def14a.htm","label":"sec_proxy","evidence_state":"verified"}],"claim_state":"confirmed","version":1},{"subject":"alpha:person:mark-enyedy","claim_type":"board_service","claim_value":{"tags":[],"title":"Director","period":"2023-01-01 · current","organization":"BIOMARIN PHARMACEUTICAL INC","organization_id":"biomarin-pharmaceutical-inc"},"claim_text":"Director at BIOMARIN PHARMACEUTICAL INC (2023-01-01 · current)","valid_from":null,"valid_to":null,"verification_status":"confirmed","date_precision":"period_text_only","evidence":[{"source_url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm","label":"sec_proxy","evidence_state":"verified"}],"claim_state":"confirmed","version":1}],"network":{"schema_version":"alpha-profile-network-public-v1","relationships":[],"relationship_pathfinding":false,"authentication_prompt":"Sign in to see how you're connected.","limitations":["Representative factual associations only.","Shared contexts do not assert personal acquaintance.","Anonymous graph traversal is not available."]},"permissions":{"classification":"open_public_projection","public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false},"limitations":["Only permissioned public claims and evidence are included.","Absence of a claim is not evidence that the underlying fact is false.","Public retrieval does not grant model-training or redistribution rights.","Private relationships and Council activity are excluded."],"structured_data":{"@context":"https://schema.org","@type":"ProfilePage","@id":"https://registry.alpha.ac/people/mark-enyedy#profile","url":"https://registry.alpha.ac/people/mark-enyedy","dateModified":"2026-05-16T03:50:21.697+00:00","primaryImageOfPage":{"@type":"ImageObject","@id":"https://registry.alpha.ac/people/mark-enyedy#portrait","identifier":"alpha-profile-portrait:mark-enyedy:v1","contentUrl":"https://qzvwmfoixeflcbvpqboy.supabase.co/storage/v1/object/public/director-photos/directors/032e2d04-f9bd-4a6c-9eb7-96bcfed740ee.jpg","url":"https://qzvwmfoixeflcbvpqboy.supabase.co/storage/v1/object/public/director-photos/directors/032e2d04-f9bd-4a6c-9eb7-96bcfed740ee.jpg","caption":"Mark Enyedy profile portrait","creditText":"Alpha governed canonical profile record","datePublished":"2026-09-02T02:37:23.760549+00:00","representativeOfPage":true},"mainEntity":{"@type":"Person","@id":"https://registry.alpha.ac/people/mark-enyedy#person","name":"Mark Enyedy","image":{"@type":"ImageObject","@id":"https://registry.alpha.ac/people/mark-enyedy#portrait","identifier":"alpha-profile-portrait:mark-enyedy:v1","contentUrl":"https://qzvwmfoixeflcbvpqboy.supabase.co/storage/v1/object/public/director-photos/directors/032e2d04-f9bd-4a6c-9eb7-96bcfed740ee.jpg","url":"https://qzvwmfoixeflcbvpqboy.supabase.co/storage/v1/object/public/director-photos/directors/032e2d04-f9bd-4a6c-9eb7-96bcfed740ee.jpg","caption":"Mark Enyedy profile portrait","creditText":"Alpha governed canonical profile record","datePublished":"2026-09-02T02:37:23.760549+00:00","representativeOfPage":true},"url":"https://registry.alpha.ac/people/mark-enyedy","jobTitle":"Independent Director","worksFor":{"@type":"Organization","name":"Charles River Laboratories","tickerSymbol":"NYSE: CRL"},"affiliation":[{"@type":"OrganizationRole","roleName":"Independent Director","startDate":"2025-01-01","memberOf":{"@type":"Organization","name":"Charles River Laboratories","url":"https://registry.alpha.ac/companies/charles-river-laboratories-international-inc","tickerSymbol":"NYSE: CRL"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2023-01-01","memberOf":{"@type":"Organization","name":"BIOMARIN PHARMACEUTICAL INC","url":"https://registry.alpha.ac/companies/biomarin-pharmaceutical-inc","tickerSymbol":"NASDAQ: BMRN"}}]},"isBasedOn":[{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1100682/000110465926037367/tm261421-1_def14a.htm","name":"CRL DEF 14A director slate"},{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm","name":"BMRN DEF 14A director slate"}],"mainEntityOfPage":"https://registry.alpha.ac/people/mark-enyedy"},"trust":{"schema_version":"alpha-profile-trust-v1","verification":{"schema_version":"alpha-verification-states-v1","state":"corroborated","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":9,"corroborated":1,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"At least one published claim is corroborated by two or more public sources. Profile ownership is unclaimed."},"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":10,"under_review_claim_count":0,"owner_supplied_claim_count":0,"evidence_record_count":6,"distinct_source_count":2,"conflicts":[],"conflict_count":0,"headline_conflict_count":0,"internal_review_conflict_count":0,"contradiction_types":[],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"corroborated","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":9,"corroborated":1,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"At least one published claim is corroborated by two or more public sources. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":10,"corroborated_claims":1,"sources":6,"distinct_sources":2,"role_claims":2,"last_reviewed_at":"2026-05-16T03:50:21.697+00:00","observed_at":"2026-09-21T16:56:42.362266+00:00","freshness_days":129}},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"}},"projection":{"schema_version":"alpha-profile-projection-v5","entity":{"kind":"person","slug":"mark-enyedy","canonical_url":"https://registry.alpha.ac/people/mark-enyedy"},"publication":{"published_at":"2026-09-02T02:37:23.760549+00:00","last_reviewed_at":"2026-05-16T03:50:21.697+00:00","as_of":"2026-09-21T16:56:42.362266+00:00"},"representations":{"html":{"href":"https://registry.alpha.ac/people/mark-enyedy","media_type":"text/html"},"json":{"href":"https://registry.alpha.ac/api/public/profiles/mark-enyedy","media_type":"application/json"},"markdown":{"href":"https://registry.alpha.ac/people/mark-enyedy.md","media_type":"text/markdown"},"structured_data":{"embedded":true,"media_type":"application/ld+json"},"share_image":null},"permissions":{"public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false}}}